Thermo Fisher Scientific Inc.

BVL:TMO Stock Report

Market Cap: US$209.2b

Thermo Fisher Scientific Past Earnings Performance

Past criteria checks 4/6

Thermo Fisher Scientific has been growing earnings at an average annual rate of 5.9%, while the Life Sciences industry saw earnings growing at 15.4% annually. Revenues have been growing at an average rate of 10.9% per year. Thermo Fisher Scientific's return on equity is 12.5%, and it has net margins of 14.5%.

Key information

5.9%

Earnings growth rate

6.7%

EPS growth rate

Life Sciences Industry Growth9.9%
Revenue growth rate10.9%
Return on equity12.5%
Net Margin14.5%
Last Earnings Update28 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Thermo Fisher Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BVL:TMO Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
28 Sep 2442,3706,1358,5121,343
29 Jun 2442,3466,2208,4691,316
30 Mar 2442,4926,0348,4341,322
31 Dec 2342,8575,9958,3811,337
30 Sep 2343,4215,9418,4641,401
01 Jul 2343,5245,7218,6531,433
01 Apr 2343,8076,0248,7811,453
31 Dec 2244,9156,9508,9401,471
01 Oct 2244,1677,0328,8541,472
02 Jul 2242,8207,4398,6111,472
02 Apr 2241,1237,6038,3171,450
31 Dec 2139,2117,7257,8571,406
02 Oct 2139,0598,5657,8431,390
03 Jul 2138,2508,5967,4621,335
03 Apr 2135,8947,9247,1991,256
31 Dec 2032,2186,3756,9401,181
26 Sep 2028,4974,8796,3601,067
27 Jun 2026,2483,7066,2921,018
28 Mar 2025,6473,6696,1141,000
31 Dec 1925,5423,6966,1391,003
28 Sep 1925,2203,5926,060992
29 Jun 1924,8683,5416,025985
30 Mar 1924,6303,1746,033981
31 Dec 1824,3582,9386,022967
29 Sep 1823,8982,5706,022949
30 Jun 1823,0942,3955,888926
31 Mar 1822,0062,2565,632906
31 Dec 1720,9182,2285,428887
30 Sep 1719,8242,3305,214867
01 Jul 1719,1992,2705,064833
01 Apr 1718,7442,1744,999794
31 Dec 1618,2742,0254,883754
01 Oct 1617,9731,9994,814723
02 Jul 1617,6062,0034,711711
02 Apr 1617,3411,9984,639703
31 Dec 1516,9651,9804,566692
26 Sep 1516,8061,9784,633695
27 Jun 1516,8541,9714,732698
28 Mar 1516,9051,7384,823707
31 Dec 1416,8901,8964,788691
27 Sep 1415,8641,6354,415613
28 Jun 1414,8841,4824,031534
29 Mar 1413,8021,4813,638447
31 Dec 1313,0901,2793,373396

Quality Earnings: TMO has high quality earnings.

Growing Profit Margin: TMO's current net profit margins (14.5%) are higher than last year (13.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: TMO's earnings have grown by 5.9% per year over the past 5 years.

Accelerating Growth: TMO's earnings growth over the past year (3.3%) is below its 5-year average (5.9% per year).

Earnings vs Industry: TMO earnings growth over the past year (3.3%) exceeded the Life Sciences industry -4.5%.


Return on Equity

High ROE: TMO's Return on Equity (12.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies